bevacizumab,atezolizumab
roche
['deliver,(-delivered),(-delivery),(-delivers),(-delivering)', 'bevacizumab', 'bcsm', 'hcc', 'atezo']
combined adjuvant treatment with atezolizumab and bevacizumab was determined to deliver a statistically significant recurrence-free survival benefit to patients with resected hepatocellular carcinoma. #aacr #hcc #hpbcsm #oncology #nursing #aacr23 
Capturing the voice of nursing professionals in the oncology news landscape.